441 related articles for article (PubMed ID: 31096567)
1. The Crowded Crosstalk between Cancer Cells and Stromal Microenvironment in Gynecological Malignancies: Biological Pathways and Therapeutic Implication.
De Nola R; Menga A; Castegna A; Loizzi V; Ranieri G; Cicinelli E; Cormio G
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096567
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
[TBL] [Abstract][Full Text] [Related]
3. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG
Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661
[TBL] [Abstract][Full Text] [Related]
4. Stromal-epithelial crosstalk provides a suitable microenvironment for the progression of ovarian cancer cells in vitro.
Fu S; Dong L; Sun W; Xu Y; Gao L; Miao Y
Cancer Invest; 2013 Nov; 31(9):616-24. PubMed ID: 24147897
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming of the tumour microenvironment.
Xing Y; Zhao S; Zhou BP; Mi J
FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
[TBL] [Abstract][Full Text] [Related]
6. Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer.
Duechler M; Peczek L; Szubert M; Suzin J
Anticancer Res; 2014 Jun; 34(6):2811-9. PubMed ID: 24922644
[TBL] [Abstract][Full Text] [Related]
7. The analysis of metallothionein immunoreactivity in stromal fibroblasts and macrophages in cases of uterine cervical carcinoma with respect to both the local and distant spread of the disease.
Walentowicz-Sadlecka M; Koper A; Krystyna G; Koper K; Basta P; Mach P; Skret-Magierlo J; Dutsch-Wicherek M; Sikora J; Grabiec M; Kazmierczak W; Wicherek L
Am J Reprod Immunol; 2013 Sep; 70(3):253-61. PubMed ID: 23590599
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment: The culprit for ovarian cancer metastasis?
Luo Z; Wang Q; Lau WB; Lau B; Xu L; Zhao L; Yang H; Feng M; Xuan Y; Yang Y; Lei L; Wang C; Yi T; Zhao X; Wei Y; Zhou S
Cancer Lett; 2016 Jul; 377(2):174-82. PubMed ID: 27131957
[TBL] [Abstract][Full Text] [Related]
9. Dynamic crosstalk within the tumor microenvironment of uterine cervical carcinoma: baseline network, iatrogenic alterations, and translational implications.
De Nola R; Loizzi V; Cicinelli E; Cormio G
Crit Rev Oncol Hematol; 2021 Jun; 162():103343. PubMed ID: 33930531
[TBL] [Abstract][Full Text] [Related]
10. Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma.
Li M; Li G; Kiyokawa J; Tirmizi Z; Richardson LG; Ning J; Das S; Martuza RL; Stemmer-Rachamimov A; Rabkin SD; Wakimoto H
Acta Neuropathol Commun; 2020 Dec; 8(1):221. PubMed ID: 33308315
[TBL] [Abstract][Full Text] [Related]
11. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer.
Luo X; Xu J; Yu J; Yi P
Front Immunol; 2021; 12():692360. PubMed ID: 34248988
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer.
Ojalvo LS; Thompson ED; Wang TL; Meeker AK; Shih IM; Fader AN; Cimino-Mathews A; Emens LA
Hum Pathol; 2018 Apr; 74():135-147. PubMed ID: 29288043
[TBL] [Abstract][Full Text] [Related]
13. Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Benhadjeba S; Edjekouane L; Sauvé K; Carmona E; Tremblay A
Mol Oncol; 2018 Oct; 12(10):1689-1705. PubMed ID: 30051594
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
Thibault B; Castells M; Delord JP; Couderc B
Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
[TBL] [Abstract][Full Text] [Related]
15. Estrogen signaling ability in human endometrial cancer through the cancer-stromal interaction.
Matsumoto M; Yamaguchi Y; Seino Y; Hatakeyama A; Takei H; Niikura H; Ito K; Suzuki T; Sasano H; Yaegashi N; Hayashi S
Endocr Relat Cancer; 2008 Jun; 15(2):451-63. PubMed ID: 18508998
[TBL] [Abstract][Full Text] [Related]
16. Selective targeting of interferon γ to stromal fibroblasts and pericytes as a novel therapeutic approach to inhibit angiogenesis and tumor growth.
Bansal R; Tomar T; Ostman A; Poelstra K; Prakash J
Mol Cancer Ther; 2012 Nov; 11(11):2419-28. PubMed ID: 22933708
[TBL] [Abstract][Full Text] [Related]
17. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.
Thuwajit C; Ferraresi A; Titone R; Thuwajit P; Isidoro C
Med Res Rev; 2018 Jul; 38(4):1235-1254. PubMed ID: 28926101
[TBL] [Abstract][Full Text] [Related]
18. A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
[TBL] [Abstract][Full Text] [Related]
19. Paracrine interactions between primary human macrophages and human fibroblasts enhance murine mammary gland humanization in vivo.
Fleming JM; Miller TC; Kidacki M; Ginsburg E; Stuelten CH; Stewart DA; Troester MA; Vonderhaar BK
Breast Cancer Res; 2012 Jun; 14(3):R97. PubMed ID: 22731827
[TBL] [Abstract][Full Text] [Related]
20. Endometrial Tumour Microenvironment.
Casas-Arozamena C; Abal M
Adv Exp Med Biol; 2020; 1296():215-225. PubMed ID: 34185295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
